Synthesis and Biological Evaluation of Vancomycin Dimers with Potent Activity against Vancomycin-Resistant Bacteria: Target-Accelerated Combinatorial Synthesis
|
journal
|
September 2001 |
Formation of the glycan chains in the synthesis of bacterial peptidoglycan
|
journal
|
March 2001 |
Rotational-Echo Double Resonance Characterization of the Effects of Vancomycin on Cell Wall Synthesis in Staphylococcus aureus †
|
journal
|
October 2002 |
Targeting a cell wall biosynthesis hot spot
|
journal
|
January 2017 |
Structure of vancomycin and its complex with acetyl-D-alanyl-D-alanine
|
journal
|
January 1978 |
Crystal structure of vancomycin
|
journal
|
December 1996 |
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
|
journal
|
July 1988 |
Identification of vancomycin resistance protein VanA as a D-alanine:D-alanine ligase of altered substrate specificity
|
journal
|
February 1991 |
Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA
|
journal
|
October 1991 |
Mechanisms and implications of glycopeptide resistance in enterococci
|
journal
|
September 1991 |
Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci.
|
journal
|
April 1992 |
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
|
journal
|
April 2003 |
Synergism between β-Lactams and Glycopeptides against VanA-Type Methicillin-Resistant Staphylococcus aureus and Heterologous Expression of the vanA Operon
|
journal
|
September 2006 |
Structure-Activity Relationships in the Series of Eremomycin Carboxamides.
|
journal
|
January 2000 |
The Role of Hydrophobic Side Chains as Determinants of Antibacterial Activity of Semisynthetic Glycopeptide Antibiotics.
|
journal
|
January 1997 |
Partitioning the Loss in Vancomycin Binding Affinity for d -Ala- d -Lac into Lost H-Bond and Repulsive Lone Pair Contributions
|
journal
|
August 2003 |
Chemical Modification of Antibiotic Eremomycin at the Asparagine Side Chain.
|
journal
|
January 1999 |
Glycopeptide antibiotics: Back to the future
|
journal
|
August 2014 |
Reductive Alkylation of Glycopeptide Antibiotics: Synthesis and Antibacterial Activity.
|
journal
|
January 1996 |
Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University Hospital
|
journal
|
December 2009 |
Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci
|
journal
|
November 2016 |
Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium
|
journal
|
April 2009 |
Desleucyl-Oritavancin with a Damaged d -Ala- d -Ala Binding Site Inhibits the Transpeptidation Step of Cell-Wall Biosynthesis in Whole Cells of Staphylococcus aureus
|
journal
|
March 2017 |
Hidden Mode of Action of Glycopeptide Antibiotics: Inhibition of Wall Teichoic Acid Biosynthesis
|
journal
|
April 2017 |
Inhibition of Staphylococcus aureus Cell Wall Biosynthesis by Desleucyl-Oritavancin: a Quantitative Peptidoglycan Composition Analysis by Mass Spectrometry
|
journal
|
May 2017 |
Oritavancin Exhibits Dual Mode of Action to Inhibit Cell-Wall Biosynthesis in Staphylococcus aureus
|
journal
|
March 2008 |
Vancomycin and Oritavancin Have Different Modes of Action in Enterococcus faecium
|
journal
|
October 2009 |
Redesign of Glycopeptide Antibiotics: Back to the Future
|
journal
|
February 2012 |
Total Synthesis of [Ψ[C(═S)NH]Tpg 4 ]Vancomycin Aglycon, [Ψ[C(═NH)NH]Tpg 4 ]Vancomycin Aglycon, and Related Key Compounds: Reengineering Vancomycin for Dual d -Ala- d -Ala and d -Ala- d -Lac Binding
|
journal
|
December 2011 |
A Redesigned Vancomycin Engineered for Dual d -Ala- d -Ala and d -Ala- d -Lac Binding Exhibits Potent Antimicrobial Activity Against Vancomycin-Resistant Bacteria
|
journal
|
September 2011 |
Insights into Key Interactions between Vancomycin and Bacterial Cell Wall Structures
|
journal
|
January 2018 |
Structure-activity relationships of vancomycin-type glycopeptide antibiotics.
|
journal
|
January 1993 |
The Vancomycin Group of Antibiotics and the Fight against Resistant Bacteria
|
journal
|
May 1999 |
Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations
|
journal
|
November 2010 |
Free energy calculations on dimer stability of the HIV protease using molecular dynamics and a continuum solvent model 1 1Edited by B. Honig
|
journal
|
November 2000 |
Crystal Structures of the Complexes between Vancomycin and Cell-Wall Precursor Analogs
|
journal
|
February 2009 |
CHARMM Additive All-Atom Force Field for Carbohydrate Derivatives and Its Utility in Polysaccharide and Carbohydrate–Protein Modeling
|
journal
|
August 2011 |
Automation of the CHARMM General Force Field (CGenFF) II: Assignment of Bonded Parameters and Partial Atomic Charges
|
journal
|
November 2012 |
GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation
|
journal
|
February 2008 |
P-LINCS: A Parallel Linear Constraint Solver for Molecular Simulation
|
journal
|
December 2007 |
REDOR constraints on the peptidoglycan lattice architecture of Staphylococcus aureus and its FemA mutant
|
journal
|
January 2015 |
g_mmpbsa —A GROMACS Tool for High-Throughput MM-PBSA Calculations
|
journal
|
June 2014 |
Calculating Structures and Free Energies of Complex Molecules: Combining Molecular Mechanics and Continuum Models
|
journal
|
December 2000 |